NCT01467219View on ClinicalTrials.gov

Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Endometrial Cancer
Interventions
PROCEDURE

lymphadenectomy

bilateral pelvic and para-aortic lymph node dissection

PROCEDURE

therapeutic conventional therapy

hysterectomy, bilateral salpingo-oophorectomy,bilateral pelvic and para-aortic lymph node dissection +/- omentectomy via laparotomy, laparoscopy or robotic-assisted

PROCEDURE

Positron Emission Tomography/ Computed Tomography

Pre-operative PET/CT scan

RADIATION

fludeoxyglucose F 18

5 MBq/kg body weight of FDG (up to 550 MBq)

Trial Locations (1)

M5T 2M9

University Health Network - Princess Margaret Cancer Center, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT01467219 - Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer | Biotech Hunter | Biotech Hunter